Table 6 Outcome comparison in the UKD-LEOSS matched pairs.

From: Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort

Total nr

UKD (cases)

LEOSS (controls)

p-value

55

220

 

Survival

Died/Total (%)

Died/Total (%)

0.345

23/55 (41.8)

75/220 (34.1)

Hospital stay

0.031

 < 4 days

2 (3.6)

31 (14.1)

4–13 days

18 (32.7)

86 (39.1)

 ≥ 14 days

35 (63.7)

103 (46.8)

ICU stay

 < 0.001

None

19 (34.5)

46 (20.1)

 < 3 days

2 (3.6)

82 (37.3)

3–15 days

20 (36.4)

42 (19.1)

 ≥ 15 days

14 (25.5)

38 (17.3)

  1. *For 11 patients in the LEOSS controls cohort, data regarding ICU stay was not available. They were not included in analysis.
  2. Significant values are in [bold].
Back to article page